OR 10 - Interventricular differences in the contribution of TREK-1 to cardiac action potential in mice

13 June 2023 (11:36 - 11:54)

Organised by:

4 More presentations in this session

Presentation thumbnail

Atrial hiPSC as a pharmacological model for human atrium

Doctor T. Christ (Hamburg, DE)

Presentation thumbnail

OR 09 - Istaroxime follow-on compounds: a new class of selective SERCA2a activators as first-in-class drug candidates for heart failure treatment

Mrs M. Arici (Milan, IT)

Presentation thumbnail

OR 11 - In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

Doctor L. Giammarino (Rochester, US)

Presentation thumbnail

OR 12 - The effects of ABT-333 (dasabuvir) on the electrophysiology of the canine left ventricular cardiomyocytes and expressed hERG channels

Mr Z. Kovacs (Debrecen, HU)

Access the full session

Session thumbnail

Session 4: Pharmacology of Ion Channels

The Event

47th EWGCCE Meeting 2023

13 June 2023 11:36 CET

You may be interested in

Congress Session

Novel mechanisms in arrhythmogenic cardiac diseases

2 September 2024

Congress Presentation

Characterization of cardiac effects of OPA1 protein promotion in transgenic animal model

28 August 2022

Congress Presentation

Assessment of repolarization dispersion by using endocardial unipolar electrograms in patients with brugada syndrome and spontaneous coved-type electrocardiographic pattern

25 August 2023

Congress Presentation

The transcription factor ETV1 regulates expression of the atrial specific potassium channel TASK-1 and modulates cardiac action potentials

27 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources